Evidence map›Paper›PMID 27067015›Full record

SynthesisMolecular psychiatry2016

Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci.

D J Smith, V Escott-Price, G Davies, M E S Bailey, L Colodro-Conde, J Ward, A Vedernikov, R Marioni, B Cullen, D Lyall and 22 more

Erratum issuedOpen access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Molecular psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 10 pooled it
37.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 10 syntheses or guidelines pooled it, 264 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Genetic risk variants for social anxiety.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Pooled it
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 8 institutions in 3 countries.

D J SmithInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
V Escott-PriceMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.ORCID 0000-0003-1784-5483
G DaviesCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
M E S BaileySchool of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
L Colodro-CondeQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
J WardInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
A VedernikovMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
R MarioniCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
B CullenInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
D LyallInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
S P HagenaarsCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
D C M LiewaldCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
M LucianoCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
C R GaleCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
S J RitchieCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
C HaywardMedical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
B NichollInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
B Bulik-SullivanProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
M AdamsDivision of Psychiatry, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-3599-6018
B Couvy-DuchesneQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
N GrahamInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
D MackayInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
J EvansInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
B H SmithGeneration Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
D J PorteousCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
S E MedlandQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
N G MartinQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
P HolmansMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
A M McIntoshCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
J P PellInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
I J DearyCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
M C O'DonovanMRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
University of Glasgow · GBUniversity of Edinburgh · GBQIMR Berghofer Medical Research Institute · AUCardiff University · GBEdinburgh Cancer Research · GBBroad Institute · USSouthampton General Hospital · GBUniversity of Dundee · GB

Funding

Biotechnology and Biological Sciences Research CouncilBritish Heart FoundationChief Scientist Office CZD/16/6Medical Research Council MC_PC_15018Medical Research Council MC_QA137853Medical Research Council MR/K026992/1Medical Research Council MR/L010305/1Medical Research Council MR/L023784/2Wellcome Trust 104036Wellcome Trust 104036/Z/14/Z
6 · The paper itself

Abstract

Neuroticism is a personality trait of fundamental importance for psychological well-being and public health. It is strongly associated with major depressive disorder (MDD) and several other psychiatric conditions. Although neuroticism is heritable, attempts to identify the alleles involved in previous studies have been limited by relatively small sample sizes. Here we report a combined meta-analysis of genome-wide association study (GWAS) of neuroticism that includes 91 370 participants from the UK Biobank cohort, 6659 participants from the Generation Scotland: Scottish Family Health Study (GS:SFHS) and 8687 participants from a QIMR (Queensland Institute of Medical Research) Berghofer Medical Research Institute (QIMR) cohort. All participants were assessed using the same neuroticism instrument, the Eysenck Personality Questionnaire-Revised (EPQ-R-S) Short Form's Neuroticism scale. We found a single-nucleotide polymorphism-based heritability estimate for neuroticism of ∼15% (s.e.=0.7%). Meta-analysis identified nine novel loci associated with neuroticism. The strongest evidence for association was at a locus on chromosome 8 (P=1.5 × 10(-15)) spanning 4 Mb and containing at least 36 genes. Other associated loci included interesting candidate genes on chromosome 1 (GRIK3 (glutamate receptor ionotropic kainate 3)), chromosome 4 (KLHL2 (Kelch-like protein 2)), chromosome 17 (CRHR1 (corticotropin-releasing hormone receptor 1) and MAPT (microtubule-associated protein Tau)) and on chromosome 18 (CELF4 (CUGBP elav-like family member 4)). We found no evidence for genetic differences in the common allelic architecture of neuroticism by sex. By comparing our findings with those of the Psychiatric Genetics Consortia, we identified a strong genetic correlation between neuroticism and MDD and a less strong but significant genetic correlation with schizophrenia, although not with bipolar disorder. Polygenic risk scores derived from the primary UK Biobank sample captured ∼1% of the variance in neuroticism in the GS:SFHS and QIMR samples, although most of the genome-wide significant alleles identified within a UK Biobank-only GWAS of neuroticism were not independently replicated within these cohorts. The identification of nine novel neuroticism-associated loci will drive forward future work on the neurobiology of neuroticism and related phenotypes.

Indexed as

AllelesAnxiety DisordersBipolar DisorderFemaleGenetic Association StudiesGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMajor Depressive DisorderMaleMultifactorial InheritanceNeuroticismPolymorphism, Single NucleotideQueenslandRisk Factors

Identifiers

PMID27067015
PMCPMC4879189
OpenAlexW2951964571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.